N/A
Completed N=152
Improving ADHD Teen Driving
Attention Deficit Disorder · Attention Deficit Disorder With Hyperactivity
Source: ClinicalTrials.gov NCT02848092 ↗
Enrolled (actual)
152
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcomePrimary: Number of Extended Glances Away From Roadway During Driving Simulation — 16.5; 28.0 number of long glances — p=<.0001
Summary
Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention (i.e., looking away from the roadway to perform secondary tasks). A driving intervention that trains teens to reduce instances of looking away from the roadway will be tested in teens with ADHD.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Extended Glances Away From Roadway During Driving Simulation |
15.7; 27.0 | <.0001 sig |
| PRIMARY Standard Deviation of Lateral Position During Driving Simulation |
.98; 1.20 | <.0001 sig |
| SECONDARY Number of Incidents, Crashes, and Near-crashes Recorded With DriveCam |
110; 159 | — |
| SECONDARY Number of DriveCam Events That Are Preceded by a 2 Second or Greater Glance Away From the Roadway |
588; 674 | — |
Eligibility Criteria
Inclusion Criteria
- Aged 16-19.
- Must meet DSM-5 ADHD criteria for ADHD-Predominantly Inattentive Presentation or ADHD-Combined Presentation based on the K-SADS interview.
- Possess a valid driver's license and regularly spend at least 3 hours per week engaged in unsupervised driving.
- IQ ≥80 as measured by the Wechsler Abbreviated Intelligence Scale-II (WASI-II)
- Parent willing to participate..
Exclusion Criteria
- On ADHD medication that cannot be washed out on assessment days.
- Drug or alcohol dependence according to K-SADS interview.
- On psychotropic or neuroleptic medications.
- Require eye glasses (contacts acceptable) for driving (corrective vision restriction on driver's license).
Data sourced from ClinicalTrials.gov (NCT02848092). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.